---
figid: PMC8034476__JCMM-25-3175-g002
figtitle: Mechanism and regulatory axis of PTHR1 in osteosarcoma
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Danio rerio
- Canis lupus familiaris
organisms_ner:
- Rattus norvegicus
- Canis lupus familiaris
- Homo sapiens
- Mus musculus
- Danio rerio
- Drosophila melanogaster
pmcid: PMC8034476
filename: JCMM-25-3175-g002.jpg
figlink: pmc/articles/PMC8034476/figure/jcmm16420-fig-0002/
number: F2
caption: Potential mechanism and regulatory axis of PTHR1 in osteosarcoma. (A) Related
  to TGF‐b1 and connective tissue growth factor; (B) Wnt signal pathway and RANKL
  regulation; (C) potential downstream genes (ZFPM2, LEF1, NR4A2, HAS2 and RHOC);
  (D) potential downstream genes (DKK1, LEF1, Agt‐CCR3 and Agt‐CCL9); (E) MMP‐2/9
  regulation; (F) VMP1 regulation; (G) regulated by LINC01278/ miR‐133a‐3p; and (H)
  potential regulatory axis (miR‐124‐3p‐AR‐Tgfb1i1, miR‐27a‐3p‐PPARG‐Abca1 and miR‐103/590‐3p‐AXIN2).
  RANKL, TNF superfamily member 11; ZFPM2, zinc finger protein, FOG family member
  2; LEF1, lymphoid enhancer–binding factor 1; NR4A2, nuclear receptor subfamily 4
  group A member 2; HAS2, hyaluronan synthase 2; RHOC, ras homolog family member C;
  DKK1, dickkopf WNT signalling pathway inhibitor 1; MMP‐2/9, matrix metallopeptidase
  2/9; and VMP1, vacuole membrane protein 1
papertitle: 'PTHR1 in osteosarcoma: Specific molecular mechanisms and comprehensive
  functional perspective.'
reftext: Chaonan Sun, et al. J Cell Mol Med. 2021 Apr;25(7):3175-3181.
year: '2021'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.7412517
figid_alias: PMC8034476__F2
figtype: Figure
redirect_from: /figures/PMC8034476__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8034476__JCMM-25-3175-g002.html
  '@type': Dataset
  description: Potential mechanism and regulatory axis of PTHR1 in osteosarcoma. (A)
    Related to TGF‐b1 and connective tissue growth factor; (B) Wnt signal pathway
    and RANKL regulation; (C) potential downstream genes (ZFPM2, LEF1, NR4A2, HAS2
    and RHOC); (D) potential downstream genes (DKK1, LEF1, Agt‐CCR3 and Agt‐CCL9);
    (E) MMP‐2/9 regulation; (F) VMP1 regulation; (G) regulated by LINC01278/ miR‐133a‐3p;
    and (H) potential regulatory axis (miR‐124‐3p‐AR‐Tgfb1i1, miR‐27a‐3p‐PPARG‐Abca1
    and miR‐103/590‐3p‐AXIN2). RANKL, TNF superfamily member 11; ZFPM2, zinc finger
    protein, FOG family member 2; LEF1, lymphoid enhancer–binding factor 1; NR4A2,
    nuclear receptor subfamily 4 group A member 2; HAS2, hyaluronan synthase 2; RHOC,
    ras homolog family member C; DKK1, dickkopf WNT signalling pathway inhibitor 1;
    MMP‐2/9, matrix metallopeptidase 2/9; and VMP1, vacuole membrane protein 1
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Tgfb1
  - Tgfbi
  - Dkk1
  - Lef1
  - Vmp1
  - Wnt2
  - Tnfsf11
  - Zfpm2
  - Nr4a2
  - Mmp9
  - Mmp2
  - Rhoc
  - Has2
  - TGFB1
  - TGFBI
  - DKK1
  - LEF1
  - VMP1
  - ZFPM2
  - NR4A2
  - MMP2
  - RHOC
  - HAS2
  - ELMO2
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - TNFSF11
  - LINC01278
  - MMP9
  - tgfb1a
  - tgfbi
  - dkk1b
  - lef1
  - vmp1
  - dre-mir-103
  - nr4a2b
  - mmp9
  - mmp2
  - has2
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - pan
  - Tango5
  - Wnt5
  - Wnt4
  - wg
  - ush
  - 124-3p
---
